NCT04324450 2025-09-04
IMPALA
Institut National de la Santé Et de la Recherche Médicale, France
Phase NA Completed
Clinical Trials
16 trialsNCT02656407 2025-09-02
FUSIMAGINE
Institut National de la Santé Et de la Recherche Médicale, France
Phase NA Completed
NCT07100600 2025-08-11
Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases
Henan Cancer Hospital
Phase 2 Recruiting
NCT05474573 2025-05-16
CONFLUENSE
Sklifosovsky Institute of Emergency Care
Phase NA Recruiting
NCT05475522 2025-05-16
SONOFLUO
Sklifosovsky Institute of Emergency Care
Phase NA Suspended
NCT05477680 2025-05-16
BRASH
Sklifosovsky Institute of Emergency Care
Phase NA Recruiting
NCT05484219 2025-05-16
FUN
Sklifosovsky Institute of Emergency Care
Phase NA Suspended
NCT05485038 2025-05-16
GAMMA
Sklifosovsky Institute of Emergency Care
Phase NA Suspended
NCT06618703 2025-02-25
BIChE-1
University Hospital, Angers
Phase NA Not yet recruiting
NCT06559566 2024-08-19
Evaluation of Postoperative Intracranial Pressure in Patients Undergoing Intracranial Tumor Surgery
Bagcilar Training and Research Hospital
Phase NA Not yet recruiting
NCT06051240 2024-04-12
LiBRA
Region Stockholm
Phase 2 Recruiting
NCT05531695 2022-09-08
ESIBAC
Hull University Teaching Hospitals NHS Trust
Phase NA Completed
NCT04778800 2021-08-31
A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)
Henan Cancer Hospital
Phase NA Unknown
NCT03010943 2020-04-27
CERVO1
University Hospital, Angers
Phase NA Completed
NCT02149459 2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1 Unknown
NCT00484978 2007-06-12
Stereotactic Radiosurgery to the Resection Cavity Following Surgical Removal of Brain Metastasis
Tel-Aviv Sourasky Medical Center
Phase 2 Unknown